CMTM6, a potential immunotherapy target.
Liang J, Li S, Li W, Rao W, Xu S, Meng H, Zhu F, Zhai D, Cui M, Xu D, Cai J, Zhang B.
Liang J, et al.
J Cancer Res Clin Oncol. 2022 Jan;148(1):47-56. doi: 10.1007/s00432-021-03835-9. Epub 2021 Nov 16.
J Cancer Res Clin Oncol. 2022.
PMID: 34783871
Review.